Actively Recruiting

Phase Not Applicable
Age: 13Years - 21Years
All Genders
ID05652153

Inhibitory Mechanisms of Negative Urgency in Adolescent Suicidal Behavior

Led by University of Minnesota · Updated on 2025-06-12

80

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

U

University of Minnesota

Lead Sponsor

N

National Institute of Mental Health (NIMH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are investigating why some adolescents with depression and suicidal thoughts or behaviors act more impulsively when experiencing negative emotions, a trait called negative urgency. This study focuses on how negative urgency relates to communication between brain cells, particularly through a process called cortical inhibition. The project aims to understand differences in brain signaling between adolescents with suicidal thoughts and those with suicidal behaviors, and how these patterns change over time. Participants aged 13 to 21 years diagnosed with depression and either suicidal ideation or suicidal behavior will be enrolled. Both groups will undergo assessments at the start of the study, and again at 6 and 12 months. These include interviews, questionnaires about emotions and impulsive behavior, computerized brain function tests, MRI brain scans, and measurements of brain cell communication using single-/paired-pulse transcranial magnetic stimulation combined with electroencephalography (TMS-EEG). During the study, adolescents will complete clinical interviews, rating scales, and self-report questionnaires about negative urgency. Brain activity will be measured using TMS-EEG at each visit. Researchers will track changes in brain inhibition and impulsivity over the year to better understand the neural mechanisms behind suicidal behavior. Safety and changes in mental health symptoms will also be monitored throughout the study period.

CONDITIONS

Brief Title

Inhibitory Mechanisms of Negative Urgency in Adolescent Suicidal Behavior

Who Can Participate

Age: 13Years - 21Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Ages 13 to 21 years (inclusive)
  • Any sex, gender, race, or ethnicity
  • Ability to provide written informed consent if 18 years or older
  • Ability to provide written assent if under 18 years, with legal guardian's consent
  • Ability to read and communicate in English
  • Current diagnosis of a unipolar depressive episode confirmed by structured interview
  • For Dep/SI group: history of suicidal ideation but no prior suicidal behavior
  • For Dep/SB group: history of suicidal behavior
  • Access to reliable internet for remote assessments if applicable
Not Eligible

You will not qualify if you...

  • Imminent suicide risk as assessed by study psychiatrist
  • Current substance use disorder within the last month (excluding caffeine and nicotine)
  • Lifetime history of psychosis, hypomania, or mania
  • Diagnosis of autism spectrum disorder or intellectual disability
  • Use of antiepileptic medication or chronic benzodiazepines (except as-needed use on study day)
  • Pregnancy or suspected pregnancy
  • Medical or neurological conditions increasing risk for TMS or MRI or impeding procedures, including seizure disorders, head injury with prolonged unconsciousness, anoxia from hanging, implanted medical devices, intracranial pressure risk, or prior brain surgery
  • Any contraindications to TMS or MRI screening
  • Non-removable hair, head, or neck modifications that interfere with TMS or EEG recording

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Longitudinal Assessments

Duration - 12 months

Participants undergo assessments including clinical interviews, questionnaires on negative urgency, and single-/paired-pulse transcranial magnetic stimulation (sp/ppTMS) to measure cortical inhibition.

3 visits (baseline, 6 months, and 12 months; in-person)

Trial Site Locations

Total: 1 location

1

University of Minnesota

Minneapolis, Minnesota, United States, 55414

Actively Recruiting

Loading map...

Research Team

C

Charles P Lewis, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Similar Trials

Targeting Suicidality in Young Adults: a Randomized, Control...

Suicidal Ideation

Actively Recruiting

13 locations

The Effects of Citalopram on the Brain's Response to Emotion...

Emotional Processing

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here